| Financial Year |
March 31 2023 |
| Monetary Funds |
671,255,005.97 |
| Held-for-trading Financial Assets |
2,360,506,486.93 |
| Notes Receivable |
3,515,000.00 |
| Accounts Receivable |
332,053,093.53 |
| Advances to Suppliers |
21,933,354.82 |
| Other Receivables |
7,825,852.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
85,649,319.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,988,840.72 |
| Total Current Assets |
3,529,807,816.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
60,846,312.26 |
| Investment Properties |
39,533,193.28 |
| Fixed Assetes |
58,745,321.80 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
733,267.26 |
| R&D expenses |
-- |
| Goodwill |
28,235,811.59 |
| Long-Term Deferred and Prepaid Expenses |
9,392,601.90 |
| Deferred Income Tax Assets |
64,807,779.97 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
305,312,683.52 |
| Total Assets |
3,835,120,499.83 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
128,224,854.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,739,825.91 |
| Taxes Payable |
2,725,002.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,395,392.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,908,192.71 |
| Other Current Liabilities |
60,505,860.89 |
| Sub-Total of Current Liabilities |
580,667,161.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,783,568.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
49,850,874.85 |
| Total Liabilities |
630,518,035.94 |
| Paid-In Capital(Or Share Stock) |
137,331,308.00 |
| Capital Surplus |
2,333,210,277.13 |
| Surplus Reserve |
54,210,321.96 |
| LESS:Treasury Stock |
29,756,121.90 |
| Undistributed Profits |
683,750,154.85 |
| Minority Stockholder's Interest |
25,856,523.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,178,745,940.04 |
| Owner's Equity（Stockholder's Equity） |
3,204,602,463.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,835,120,499.83 |
